Home LiteratureArticle Details
PMID: 22395697 Published · epublish English News Comment

Chipping away at the lung cancer genome.

Nature medicine ·Vol. 18 ·No. 3 ·2012-03-06 ·Pages 349-51

Pao W, Hutchinson KE

Abstract

暂无摘要

MeSH Terms
Adenocarcinoma/genetics Adenocarcinoma of Lung Anaplastic Lymphoma Kinase Animals Carcinoma, Non-Small-Cell Lung/genetics Colorectal Neoplasms/genetics Female Humans Kinesins/genetics Lung Neoplasms/genetics Male Oncogene Proteins, Fusion/genetics Protein-Tyrosine Kinases/genetics Proto-Oncogene Proteins/genetics Proto-Oncogene Proteins c-ret/genetics Receptor Protein-Tyrosine Kinases/genetics
Chemicals
KIF5B protein, human Oncogene Proteins, Fusion Proto-Oncogene Proteins Anaplastic Lymphoma Kinase Protein-Tyrosine Kinases Proto-Oncogene Proteins c-ret RET protein, human ROS1 protein, human Receptor Protein-Tyrosine Kinases Kinesins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Pao William
Hutchinson Katherine E
References (16)
16 references, click to expand
  1. RET, ROS1 and ALK fusions in lung cancer.
    Nat Med. 2012 Feb 12;18(3):378-81 PMID: 22327623
  2. Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer.
    J Clin Oncol. 2010 Feb 10;28(5):767-72 PMID: 20065189
  3. ROS1 rearrangements define a unique molecular class of lung cancers.
    J Clin Oncol. 2012 Mar 10;30(8):863-70 PMID: 22215748
  4. New driver mutations in non-small-cell lung cancer.
    Lancet Oncol. 2011 Feb;12(2):175-80 PMID: 21277552
  5. Global cancer statistics.
    CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 PMID: 21296855
  6. Kinesins and microtubules: their structures and motor mechanisms.
    Curr Opin Cell Biol. 2000 Feb;12(1):35-41 PMID: 10679355
  7. KIF5B-RET fusions in lung adenocarcinoma.
    Nat Med. 2012 Feb 12;18(3):375-7 PMID: 22327624
  8. Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.
    N Engl J Med. 2010 Oct 28;363(18):1693-703 PMID: 20979469
  9. Targeted next-generation sequencing of DNA regions proximal to a conserved GXGXXG signaling motif enables systematic discovery of tyrosine kinase fusions in cancer.
    Nucleic Acids Res. 2010 Nov;38(20):6985-96 PMID: 20587502
  10. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.
    Genome Res. 2012 Mar;22(3):436-45 PMID: 22194472
  11. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib.
    Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13306-11 PMID: 15329413
  12. RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis.
    Endocrinology. 2007 Mar;148(3):936-41 PMID: 16946010
  13. Activation of a novel human transforming gene, ret, by DNA rearrangement.
    Cell. 1985 Sep;42(2):581-8 PMID: 2992805
  14. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.
    Nat Med. 2012 Feb 12;18(3):382-4 PMID: 22327622
  15. Spectrum of oncogenic driver mutations in lung adenocarcinomas from East Asian never smokers.
    PLoS One. 2011;6(11):e28204 PMID: 22140546
  16. Targeting RET receptor tyrosine kinase activation in cancer.
    Clin Cancer Res. 2010 Dec 15;16(24):5936-41 PMID: 20930041
Article Info
Journal
Nature medicine
Abbr.
Nat Med
ISSN
1546-170X
Published
2012-03-06
Epub
2012-00-06
Pages
349-51
Language
English
Region
United States
NLM ID
9502015
Subset
IM
Corrections
CommentOn
CommentOn
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com